The most common, X-linked, form of chronic granulomatous disease (CGD) is caused by mutations in the CYBB gene located at Xp21.1. The product of this gene is the large subunit of flavocytochrome b 558 , gp91
Introduction
Chronic granulomatous disease (CGD) is a rare inherited disorder of the innate immune system. The disease is characterized by a severe susceptibility to infection due to the failure of phagocytic leukocytes (neutrophils, eosinophils, macrophages and monocytes) to produce microbicidal reactive oxygen species [1] . The source of these radicals is superoxide (O 2 ) generated by NADPH oxidase, a multicomponent enzyme complex. Defects in any of four components of NADPH oxidase (p47 phox , p67 phox , p22 phox or gp91 phox encoded by the NCF1, NCF2, CYBA and CYBB genes, respectively) can give rise to CGD [1, 2] . Recently, a CGD-like syndrome has been described that is caused by a mutation in a ¢fth essential component, Rac2 [3, 4] . With the exception of gp91 phox , the a¡ected genes in CGD are autosomal, and we have recently tabulated all the known mutations in these genes [5] .
The most common form of CGD is X-linked and is caused by defects in the CYBB gene that codes for the large subunit of £avocytochrome b 558 , gp91 phox , the heme and £avin-containing core of NADPH oxidase. The 30 kb CYBB gene consists of 13 exons and is located at Xp21.1. Our studies and those of others have revealed a broad distribution of family-speci¢c defects in patients with X-linked CGD. The known mutations have been recently tabulated [6] . These include small and large deletions, insertions, nonsense and missense mutations, splice site defects and, rarely, mutations in the 5P regulatory region.
To date, only two patients have been described that have gp91 phox de¢ciency arising from intronic defects within CYBB (aside from large deletions and splice site mutations). One was the result of the insertion of a LINE-1 element in intron V, followed by an internal rearrangement that generated new splice sites within the intron [7] . In the second case, we described a patient in whom a single nucleotide substitution in the middle of intron VI generated a new 3P splice site that caused a 94 bp`pseudoexon' to be inserted into the mRNA [8] . In the course of our continuing studies of mutations causing CGD, we have found and characterized another patient who has a defect arising from an intronic mutation remote from the neighboring exons. This individual had a single nucleotide substitution in intron V that generated a new 5P splice site and resulted in multiple mRNA products, one with 110 nucleotides spliced in between exons 5 and 6 and another product with 61 nucleotides spliced in.
Materials and methods

Patient
The patient is a 9-month-old boy with neutrophils that failed to reduce NBT and a history of otitis media. His mother has had a life-long history of chronic skin abscesses and was originally diagnosed as having autosomal recessive CGD as a child. On examination as an adult, she was found to have 15% positive cells in the NBT test and 10% positive by dihydrorhodamine £ow cytometry, suggestive of a carrier of X-linked CGD with skewed X-inactivation. Blood samples were obtained following the procedures approved by the Scripps Research Institute's Human Subjects Committee.
Single strand conformation polymorphism (SSCP) analysis and sequencing of exons
Genomic DNA was extracted from whole blood using the Puregene Blood Kit (Gentra Systems, MN). DNA was analyzed by SSCP as described previously [8] using 18^27 bp oligonucleotide primers and 500 ng genomic DNA. Ampli¢cation products were run on 20% TBE gels in a Thermo£ow unit (Invitrogen (formerly Novex), Carlsbad, CA). SSCP analysis was performed on the 5P £anking region from 171 bp from the start of the coding region, through all 13 exons, and 26 bp of the 3P untranslated region. Other DNA sequencing was performed as described previously and as described below [9, 10] .
Nuclear run-on assays
Transcription of the CYBB gene encoding gp91 phox in B cell lines from the patient and a normal control was assessed by nuclear run-on transcription assays with minor modi¢cations of previously published procedures [11] . Epstein^Barr virus (EBV)-transformed B cells were derived from peripheral blood and cultured in RPMI 1640 medium (supplemented with 10% heat inactivated fetal bovine serum, 2 mM L-glutamine, 100 U/ml penicillin, and 100 Wg/ml streptomycin) as previously described [12] . Nuclei were isolated by cell lysis in 0.05% Nonidet P-40 and immediately incubated for 30 min at 30³C in a reaction mixture containing [ 32 P]UTP (250 WCi, 3000 Ci/mmol) in bu¡er modi¢ed from Greenberg et al.
[11] by addition of 0.8 mM MnCl 2 . Newly synthesized RNA was extracted by the guanidine HCl method [13] . Equal amounts of incorporated label from each sample (1^2U10 7 cpm) were then hybridized to saturating amounts of cDNA probes, immobilized on ¢lters by slot blotting. The probes used in these experiments included cDNAs for the genes encoding gp91
phox , p22 phox , and p47 phox , a hybridization negative control (plasmid without insert), and the constitutively expressed gene for KK1-tubulin [14] . Relative rates of transcription were calculated by computer analysis of phosphorimager data, with normalization to negative control slots for each ¢lter.
Sequencing of the 3P region
Only 14 bp of sequence 3P of the polyadenylation signal were known (GenBank accession No. NM_000397.1) so an additional 3P sequence was needed to design a primer in order to amplify this region. The necessary sequence was obtained from PAC clone 7287 (which contains the entire CYBB gene) by performing a PCR reaction using a SP6 primer modi¢ed to increase speci¢city (SP6m), and a primer 63 bp 5P of the poly(A) signal (poly(A-F)) employing the Expand Long Template PCR system (Roche, Indianapolis, IN) under the following conditions: an initial denaturation at 95³C for 3 min followed by 10 cycles of 95³C for 30 s, 60³C for 30 s, and 68³C for 4 min, then 20 cycles of 95³C for 30 s, 60³C for 30 s, and 68³C for 4 min with a cycle elongation of 20 s, followed by a 7 min extension at 68³C. The resulting 3 kb product was partially sequenced and an additional 343 bp of sequence 3P of the poly(A) region was obtained. A primer (poly(A-R)) was designed from this sequence and used to amplify a 281 bp region containing the poly(A) signal. The remaining 2385 bp of the 3PUTR was ampli¢ed with a primer 50 bp 3P of exon 13 (3PUTR1) and a reverse primer 106 bp 5P of the poly(A) signal (poly(A-R3)) using Expand Long Template as follows: an initial denaturation at 95³C for 3 min followed by 10 cycles of 94³C for 15 s, 60³C for 30 s, and 68³C for 2 min, then 20 cycles of 94³C for 15 s, 60³C for 30 s, and 68³C for 2 min with a cycle elongation of 20 s, followed by a 7 min extension at 68³C, with sequencing in 11 steps.
mRNA analysis
mRNA was analyzed using RNA isolated from whole blood using the RNeasy Kit (Qiagen, Valencia, CA). cDNA was prepared using RT-PCR (cDNA kit, Life Technologies, Rockville, MD) using a forward primer from exon 1 and a reverse primer from exon 13. The cDNA products were visualized on agarose gels using ethidium bromide.
Sequencing of intron V
Sequencing of intron V was achieved by ¢rst amplifying the region from exon 5 to 6 by PCR using Expand High Fidelity under the following conditions: an initial denaturation at 94³C for 3 min, followed by 10 cycles of 94³C for 15 s, 63³C for 30 s, and 68³C for 1 min and 20 s, then 20 cycles of 94³C for 15 s, 63³C for 30 s, and 68³C for 1 min and 20 s with a cycle elongation of 20 s. This was followed by a 7 min extension at 72³C. Stepwise sequencing of the entire 2.1 kb of intron V was performed in eight steps. The primers used are shown in Table 1 .
Results and discussion
Mutation analysis of the patient's exonic sequences
SSCP analysis of genomic DNA did not reveal any abnormalities in the 5P £anking region (from 171 bp upstream from the coding region) in any of the 13 exons in the 26 bp 3P of exon 13). Although our previous experience has shown that almost 95% of mutations can be detected in this way [9] , we initially sequenced all the exonic regions of DNA as described in Section 2. In keeping with the SSCP results, all the exonic sequence was found to be normal (including the intron/exon borders). An additional 222 bp were sequenced upstream, but no abnormalities were found.
CYBB gene transcription is normal in the patient
To determine if long-range (i.e. beyond 393 bp upstream from CYBB) promoter or regulatory region defects were responsible for the lack of gp91 phox , transcription rates were checked by performing nuclear run-on assays as described in Section 2. As shown in Table 2 there was no defect in transcription of the gp91 phox gene in the patient's B cells. Transcription rates for all the oxidase components were similar in the two cell lines, with marginally higher expression in the patient's, as previously observed in other CGD cell lines representing posttranscriptional molecular defects (C. Whitney and P.E. Newburger, unpublished data).
The 3P untranslated region of the patient's CYBB gene is normal
To determine if there was a defect in the 3PUTR that might lead to unstable mRNA and result in loss of gp91 phox synthesis, we sought to sequence the region 3P of the CYBB gene. As described in Section 2, initial attempts using standard SP6 and T7 primers were unsuccessful as the signal was too weak to iden-tify the correct product. We successfully designed modi¢ed primers (SP6m and T7m, Table 1 ) that improved primer speci¢city and used them in combination with the poly(A-F) primer in ampli¢cation reactions. Depending on the orientation of the CYBB gene in the PAC vector, it was predicted that one of these PCR pairs would yield a fragment containing the region of interest. A 3 kb fragment was successfully ampli¢ed by PCR using the SP6m/poly-(A-F) pair. This fragment was used to obtain 2434 bp of sequence 3P of exon 13 in 11 steps as described in Section 2. The sequence in the patient was identical to a normal control (including the polyadenylation signal) except that a tCg transversion was found at the +559 bp position. However, the patient's mother, who is a carrier of the disease and has a population of neutrophils with functional NADPH oxidase, was homozygous for this change, indicating that it is a benign polymorphism.
There is an intronic defect in the patient
For the initial analysis of exons, primers were chosen to sequence 14^22 bp into the ends of each intron in order to detect defects that could lead to aberrant splicing, but we were unable to ¢nd any such abnormalities in the patient's DNA. In order to examine the possibility that mutations deeper within the introns might cause the generation of new splice sites, the mRNA from the patient was examined. Ampli¢cation by RT-PCR of his mRNA from exons 1^13 gave only a faint smear. The quality of the mRNA sample was checked by PCR ampli¢-cation of two unrelated genes (glucose-6-phosphate dehydrogenase and p67 phox ) and normal products were obtained in both cases. RT-PCR was repeated in CYBB from exons 2^8, 3^8, 4^8 and 5^8. In the former cases only non-speci¢c products were obtained; in the case of exons 5^8, two products were obtained but of the wrong size (Table 2 ). An additional attempt to amplify the cDNA from exons 1^13 was made using 5% DMSO in the reaction mix in order to increase primer speci¢city [15] . In the patient a rather di¡use cDNA product of slightly larger Transcription rates of genes encoding gp91-phox, p22-phox, and p47-phox in EBV-transformed B lymphocytes. Representative nuclear run-on assay showing the transcription rates, in arbitrary phosphorimager density units, of the indicated genes in nuclei from normal and CGD EBV-transformed B lymphocytes. The K-tubulin gene served as a constitutive control. Table 1 Primers used for PCR and sequencing analysis Sequence Location agttggctaaccatcaga intron 5F tggatcagttatggtcagga intron 5F-1.2 cactgggagtaactcagca intron 5F-1.3 ctaggggtagccaggaggg intron 5F-3 tgaagcttcctacactca JR.i5 gtttgcccaatgatatatgag intron 5F-4 tcctattccctactctct intron 5F-4.5 ggagaaagagccttcagacac intron 5F-5 cttgcaggctttgtatgtga
The following primers were used for PCR and sequence analysis as described in Section 2. Additional primers for SSCP and sequencing are given in [9] .
size than the product from the control sample was observed, after analysis by agarose gel electrophoresis (Fig. 1) .
To further analyze this anomaly, additional primers were designed in order to perform RT-PCRs in di¡erent areas of the gene (Table 1) . Using this strategy, we were able to localize the defect to either intron IV or intron V, as normal product (although of diminished abundance) could be obtained using primers between exons 1^4 and 6^13 (Table 3 ). Intron V was ampli¢ed from genomic DNA by performing a PCR from exon 5 to 6 (2.1 kb) as described in Section 2. A single nucleotide substitution at +978 bp (gCt) generates a putative 5P splice site (ggaagaCgtaaga) (Fig. 2) . As expected, the patient's mother was found to be a carrier of this mutation (Fig. 2) . We hypothesized that as a consequence of the generation of this 5P donor site, nearby cryptic 3P acceptor site(s) might be activated. Ampli- Fig. 2 . Generation of a putative 5P splice site by a gCt transition at +978 nt in intron V. Sequencing of intron V was performed as described in Section 2. Upper trace, normal control; middle trace, the patient's mother; lower trace, patient. The arrow is below nucleotide +978 in intron V; normal control, homozygous g; patient's mother, heterozygous g/t ; patient, hemizygous t. cDNA was ampli¢ed using the primers indicated [9] and the products visualized by ethidium bromide staining and scored by eye. a Two products, both of abnormal size. ¢cation of the cDNA using primers from exons 5^8 followed by direct sequencing of the product using primer cDNA5F allowed us to identify two major mRNA species with either 61 or 110 nucleotides spliced in. Examination of the genomic sequence surrounding the mutation con¢rmed the presence of two cryptic 3P acceptor sites 61 and 110 nucleotides upstream from the 5P site. As a result, two major mRNA species are formed as shown in Fig. 3 with either 61 or 110 nucleotides spliced in between exons 5 and 6. Scoring the splice sites by the method of Shapiro and Senapathy [16] gave scores of 72 for the distal 3P site (cagcatttctctag) and 88 for the proximal 3P site (ttctatcccagcag). The newly created 5P donor site has a score of 86. 5 . Surprisingly, analysis of the 5P sequence revealed the presence of several cryptic splice sites with scores above 73 that are apparently not used (or used at low frequency), presumably due to structural restraints or because there is no suitable adenosine for lariat formation. According to Talerico and Burget [17] , normally silent 3P splice sites are recognized with high e¤ciency when point mutations create a 5P splice site within adjacent downstream intron sequences. In an attempt to identify other splice forms, exons 4^8 were ampli¢ed using primer cDNA4F. In addition to the two major products described above, a number of minor species were seen with sequences diverging after exon 4. The presence of these low-abundance products is probably the cause of the di¡use appearance of the patient's mRNA band in Fig. 1 . This study illustrates the rare event wherein an apparently insigni¢cant point mutation in`junk DNA' can result in a catastrophic lesion leading to disease.
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